Osteoclasts are not a source of SLIT3.

Area of Science:

• Bone Biology
• Cell Signaling
• Skeletal Physiology

Background:

• Recent studies identified SLIT3 as an osteoanabolic agent.
• Conflicting reports exist regarding SLIT3's cellular origin (osteoblasts vs. osteoclasts) and its effect on osteoclastogenesis.

Purpose of the Study:

• To resolve discrepancies regarding SLIT3's role and source in skeletal tissue.
• To investigate the functional significance of SLIT3 produced by osteoclasts.

Main Methods:

• Assessed SLIT3 expression during human and mouse osteoclastogenesis.
• Examined SLIT3 effects on osteoclast differentiation in vitro.
• Utilized conditional SLIT3 deletion in cathepsin K (CTSK)- and LysM-positive cells.
• Generated bone marrow chimeras from Slit3-deficient donors.

Main Results:

• No significant SLIT3 expression was detected during osteoclastogenesis.
• SLIT3 showed only modest effects on osteoclast differentiation.
• Conditional deletion of SLIT3 in osteoclast lineage cells did not alter bone mass or resorption/formation parameters.
• Bone marrow chimeras lacking SLIT3 in osteoclast development had normal bone mass.

Conclusions:

• Osteoclast-derived SLIT3 does not appear to have a significant physiologic function in bone.
• Osteoblasts are likely the predominant source of skeletal SLIT3.
• The role of SLIT3 in bone metabolism warrants further investigation, focusing on osteoblast-derived SLIT3.